Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Mar 01, 2026
War Dividend: Is General Dynamics’ (GD) Stock Built to Climb in the Iran Crisis?

War Dividend: Is General Dynamics’ (GD) Stock Built to Climb in the Iran Crisis?

General Dynamics (GD) is likely to stay biased up in the Iran war environment, with defense spending and backlog support pushing the stock gradually higher, though from already elevated levels where upside looks steady, not explosive.

General Dynamics in an Iran War Defense Cycle

General Dynamics is a diversified defense and aerospace company spanning Gulfstream business jets, combat vehicles (like the Abrams tank), IT and mission systems, and nuclear submarines through its Marine Systems segment. In 2025 it generated about 52.55 billion dollars in revenue and 4.21 billion dollars in net income, both up roughly 10–11% year over year, with EPS around 15.45 and a growing backlog reported near 118 billion dollars that provides multi‑year visibility. The stock recently trades near 357 dollars, close to a 52‑week high of 369.70 dollars, with a market cap around 96–97 billion dollars and a price‑to‑earnings ratio just above 23.

The U.S.–Iran war has triggered a classic risk‑off move in broad markets but a bid into defense: the iShares U.S. Aerospace & Defense ETF is already up about 14% in 2026, and commentary highlights that recurring maintenance and software contracts can keep cash flowing long after any single conflict ends. Barron’s notes that firms like General Dynamics are well‑positioned as submarine, shipbuilding, and land‑systems demand remain structurally strong, while the Iran strikes put additional political wind at the back of U.S. and allied defense budgets. Against this backdrop, GD’s low beta (around 0.40) and rising dividend (6 dollars annually, about a 1.7% yield) make it look like a relatively defensive way to gain exposure to a prolonged period of elevated geopolitical risk.

Key Takeaways

  • GD produces business jets, combat vehicles, IT and mission systems, and submarines, with 2025 revenue of 52.55 billion dollars, net income of 4.21 billion dollars, EPS of 15.45, and a sizable backlog near 118 billion dollars that underpins future growth.​

  • The Iran war has boosted interest in defense stocks; sector ETFs are up double digits this year and analysts emphasize that long‑duration maintenance and modernization contracts can support cash flows even after the conflict cools.

  • General Dynamics shares trade around 357 dollars, not far below a 369.70‑dollar 52‑week high, with a P/E of roughly 23 and a market cap near 96–97 billion dollars, reflecting both strong recent performance and a market willing to pay a premium for defense visibility.

  • Analyst sentiment is solid but measured: around 16–23 analysts call GD a “Buy” or “Moderate Buy,” with average 12‑month price targets ranging from about 359–376 dollars and some top targets around 395–400 dollars—implying modest single‑digit to low‑double‑digit upside from here.

  • The overall picture is of a high‑quality defense name likely to grind higher as Iran‑driven tensions and submarine/business‑jet programs support earnings, but with gains constrained by a valuation that already prices in a good chunk of that strength.

How Tickeron’s AI Tools Can Help With GD

AI‑powered platforms like Tickeron can help you navigate GD’s mix of steady fundamentals and headline‑driven sentiment. Pattern‑recognition engines can scan General Dynamics’ chart for breakouts near its 52‑week highs, pullbacks to key moving averages, and volatility spikes around Iran‑related news, then backtest how similar patterns performed during previous defense‑spending cycles. Event‑driven models that track price, volume, and sector flows can flag when GD is over‑ or under‑reacting relative to the broader defense ETF basket, providing probabilities for short‑term continuation or mean reversion rather than relying on intuition alone. Combined with fundamentals—backlog trends, analyst revisions, and valuation versus price targets—Tickeron’s AI can help you decide whether to buy GD on dips as a long‑term defense compounder or treat it as a more tactical holding during this Iran‑driven risk cycle.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: GD

GD sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for GD moved above the 200-day moving average on July 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2026. You may want to consider a long position or call options on GD as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GD just turned positive on July 23, 2026. Looking at past instances where GD's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GD advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 286 cases where GD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GD moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 76 cases where GD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GD broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. GD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.867) is normal, around the industry mean (9.796). P/E Ratio (23.379) is within average values for comparable stocks, (60.322). Projected Growth (PEG Ratio) (2.663) is also within normal values, averaging (3.945). Dividend Yield (0.016) settles around the average of (0.016) among similar stocks. P/S Ratio (1.912) is also within normal values, averaging (30.985).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 37.21B. The market cap for tickers in the group ranges from 4.49 to 1.43T. SPCX holds the highest valuation in this group at 1.43T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 5%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -1%. DFNS experienced the highest price growth at 536%, while VWAV experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -6%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 68
Price Growth Rating: 61
SMR Rating: 79
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
GD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an aerospace and defense company that offers a broad portfolio of products and services

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
11011 Sunset Hills Road
Phone
+1 703 876-3000
Employees
111600
Web
https://www.gd.com
Interact to see
Advertisement
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.